68Ga-Somatostatin Analog PET-CT Linked to Reduced Costs

This article originally appeared here.
Share this content:
<sup>68</sup>Ga-Somatostatin Analog PET-CT Linked to Reduced Costs
68Ga-Somatostatin Analog PET-CT Linked to Reduced Costs

THURSDAY, July 20, 2017 (HealthDay News) -- For imaging neuroendocrine tumors, 68Ga-somatostatin analog positron emission tomography-computed tomography (PET-CT) is associated with reduced costs compared with 111In-octreotide scintigraphy, according to a study published online July 17 in the Journal of Medical Imaging and Radiation Oncology.

Tatiana Segard, M.D., from Sir Charles Gairdner Hospital (SCGH) in Nedlands, Australia, and colleagues conducted an analysis based on retrospective clinical data from 95 111In-octreotide scintigraphies performed in 2007 and 2008 in SCGH and Royal Perth (RPH) hospital and 219 68Ga-somatostatin analog PET-CT studies conducted at SCGH in 2013. The authors derived whole body effective radiation dose from the radiopharmaceutical and low-dose CT scan. Radiopharmaceutical and imaging costs were included in the cost analysis.

The researchers found that the mean effective radiation dose was 18.1 mSv and 13.8 mSv at SCGH and RPH, respectively, for 111In-octreotide scintigraphy. For 68Ga-somatostatin analog PET-CT, the effective dose was 8.7 to 10.7 mSv. The average cost was four times lower for 68Ga-somatostatin PET-CT versus 111In-octreotide scintigraphy.

"68Ga-somatostatin analogue PET-CT is not only more accurate than 111In-octreotide scintigraphy, this study has also shown that it is significantly less expensive, delivers a lower radiation dose to patients, and requires less imaging time for patients and staff," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Ad Campaign Hopes to Halt E-Cigarette Use Among Teens

FDA Ad Campaign Hopes to Halt E-Cigarette Use ...

'The Real Cost' Youth E-Cigarette Prevention Campaign to target at-risk youth

U.S. Senate Passes Opioids Bill

U.S. Senate Passes Opioids Bill

Comprehensive bipartisan package earmarks billions of dollars to fight opioid abuse in the United States

Active Choice Intervention Tied to Increase in Flu Shot Rates

Active Choice Intervention Tied to Increase in Flu ...

Vaccination rates decrease throughout the day; with intervention, similar increase throughout day

is free, fast, and customized just for you!




Already a member?

Sign In Now »